Kura Oncology (NASDAQ:KURA – Free Report) had its target price raised by HC Wainwright from $32.00 to $37.00 in a report published on Thursday,Benzinga reports. The firm currently has a buy rating on the stock. Several other analysts also recently issued reports on the stock. JMP Securities reaffirmed a “market outperform” rating and issued a […]

Kyverna Therapeutics (NASDAQ:KYTX – Get Free Report) had its price objective cut by investment analysts at HC Wainwright from $7.00 to $6.00 in a research report issued on Wednesday,Benzinga reports. The firm currently has a “neutral” rating on the stock. HC Wainwright’s target price would suggest a potential upside of 47.06% from the stock’s previous […]

Beam Global (NASDAQ:BEEM – Get Free Report) had its price objective lowered by equities research analysts at HC Wainwright from $30.00 to $8.00 in a research note issued to investors on Tuesday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 100.00% from the […]

My Size (NASDAQ:MYSZ – Get Free Report) had its target price lowered by equities researchers at HC Wainwright from $5.00 to $3.00 in a research report issued to clients and investors on Monday,Benzinga reports. The firm presently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 96.08% from […]

Canoo (NASDAQ:GOEV – Get Free Report) had its price target reduced by equities researchers at HC Wainwright from $4.00 to $2.00 in a report issued on Friday,Benzinga reports. The brokerage currently has a “buy” rating on the stock. HC Wainwright’s price objective indicates a potential upside of 297.38% from the company’s current price. Separately, Roth […]

IN8bio (NASDAQ:INAB – Free Report) had its price target trimmed by HC Wainwright from $12.50 to $8.00 in a report released on Wednesday,Benzinga reports. The brokerage currently has a buy rating on the stock. HC Wainwright also issued estimates for IN8bio’s Q4 2024 earnings at ($0.08) EPS, FY2024 earnings at ($0.59) EPS, Q1 2025 earnings […]

IN8bio (NASDAQ:INAB – Free Report) had its price target cut by HC Wainwright from $12.50 to $8.00 in a research report sent to investors on Wednesday morning,Benzinga reports. They currently have a buy rating on the stock. HC Wainwright also issued estimates for IN8bio’s Q4 2024 earnings at ($0.08) EPS, FY2024 earnings at ($0.59) EPS, […]

ODP (NASDAQ:ODP – Free Report) had its target price lowered by UBS Group from $30.00 to $28.00 in a report published on Thursday morning,Benzinga reports. The brokerage currently has a neutral rating on the specialty retailer’s stock. Separately, StockNews.com downgraded ODP from a “buy” rating to a “hold” rating in a research report on Thursday, […]